[
  {
    "date": "2023-12-30",
    "symbol": "VNDA",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2023-12-31",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-34186",
    "entityregistrantname": "VANDA PHARMACEUTICALS INC.",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "03-0491827",
    "entityaddressaddressline1": "2200 Pennsylvania Avenue NW",
    "entityaddressaddressline2": "Suite 300 E",
    "entityaddresscityortown": "Washington",
    "entityaddressstateorprovince": "DC",
    "entityaddresspostalzipcode": 20037,
    "cityareacode": 202,
    "localphonenumber": "734-3400",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "VNDA",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "amendmentflag": "false",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entitycentralindexkey": 1347178,
    "auditorfirmid": 238,
    "auditorname": "PricewaterhouseCoopers LLP",
    "auditorlocation": "Washington, District of Columbia",
    "cashandcashequivalentsatcarryingvalue": 135821000,
    "debtsecuritiesavailableforsaleexcludingaccruedinterestcurrent": 252443000,
    "accountsreceivablenetcurrent": 34155000,
    "inventorynet": 1357000,
    "prepaidexpenseandotherassetscurrent": 9170000,
    "assetscurrent": 432946000,
    "propertyplantandequipmentnet": 2037000,
    "operatingleaserightofuseasset": 7103000,
    "finitelivedintangibleassetsnet": 121369000,
    "deferredincometaxassetsnet": 75000000,
    "inventoryandothernoncurrent": 9985000,
    "assets": 648440000,
    "accountspayableandaccruedliabilitiescurrent": 38460000,
    "productrevenueallowancescurrent": 49237000,
    "liabilitiescurrent": 87697000,
    "operatingleaseliabilitynoncurrent": 7006000,
    "otherliabilitiesnoncurrent": 8827000,
    "liabilities": 103530000,
    "commonstockvalue": 58000,
    "additionalpaidincapitalcommonstock": 700274000,
    "accumulatedothercomprehensiveincomelossnetoftax": -30000,
    "retainedearningsaccumulateddeficit": -155392000,
    "stockholdersequity": 544910000,
    "liabilitiesandstockholdersequity": 648440000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 20000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 150000000,
    "commonstocksharesissued": 57534499,
    "commonstocksharesoutstanding": 57534499,
    "revenuefromcontractwithcustomerexcludingassessedtax": 192640000,
    "revenues": 192640000,
    "costofgoodsandserviceexcludingdepreciationdepletionandamortization": 14796000,
    "researchanddevelopmentexpense": 76823000,
    "sellinggeneralandadministrativeexpense": 112883000,
    "amortizationofintangibleassets": 2090000,
    "costsandexpenses": 206592000,
    "operatingincomeloss": -13952000,
    "otherincome": 20291000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": 6339000,
    "incometaxexpensebenefit": 3830000,
    "netincomeloss": 2509000,
    "earningspersharebasic": 0.04,
    "earningspersharediluted": 0.04,
    "weightedaveragenumberofsharesoutstandingbasic": 57380975,
    "weightedaveragenumberofdilutedsharesoutstanding": 57557911,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentbeforetax": 28000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentbeforetax": 1461000,
    "othercomprehensiveincomelosstax": 326000,
    "othercomprehensiveincomelossnetoftax": 1163000,
    "comprehensiveincomenetoftax": 3672000,
    "stockissuedduringperiodsharessharebasedcompensation": 750735,
    "stockissuedduringperiodvaluesharebasedcompensation": 1000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 14040000,
    "depreciation": 920000,
    "sharebasedcompensation": 14040000,
    "investmentincomenetamortizationofdiscountandpremium": 8799000,
    "debtsecuritiesavailableforsalerealizedgainloss": -655000,
    "deferredincometaxexpensebenefit": -1286000,
    "othernoncashincomeexpense": -3419000,
    "increasedecreaseinaccountsreceivable": 707000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -8523000,
    "increasedecreaseininventories": 771000,
    "increasedecreaseinaccountspayableandaccruedliabilities": -10984000,
    "increasedecreaseproductrevenueallowances": 3192000,
    "netcashprovidedbyusedinoperatingactivities": 12801000,
    "paymentsforassetacquisitions": 100665000,
    "paymentstoacquirepropertyplantandequipment": 383000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 512606000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 601598000,
    "netcashprovidedbyusedininvestingactivities": -12056000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": 47000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 792000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 136290000,
    "accountspayableandaccruedliabilitiespolicytextblock": "Accounts Payable and Accrued Liabilities",
    "scheduleofaccountsreceivablebymajorcustomersbyreportingsegmentstabletextblock": "The following table presents each major customer that represented more than 10% of accounts receivable, net, as of December 31, 2023 and 2022: December 31,Percent of Accounts Receivable, Net20232022Customer A*18 %Customer B19 %20 %Customer C21 %14 %Customer D34 %*Customer E16 %16 %Customer F*13 %Total accounts receivable, net from major customers90 %81 %*Represents less than 10% of respective balance.",
    "secschedule1209scheduleofvaluationandqualifyingaccountstabletextblock": "The following table summarizes activity for product returns as of and for the years ended December 31, 2023, 2022 and 2021, all of which relates to sales of Fanapt",
    "scheduleofinventoriestabletextblock": "Inventory consisted of the following as of December 31, 2023 and 2022:(in thousands)December 31, 2023December 31, 2022Current assetsWork-in-process$27 $23 Finished goods1,330 1,171 Total inventory, current$1,357 $1,194 Non-Current assetsRaw materials$934 $1,043 Work-in-process7,177 8,212 Finished goods737 1,041 Total inventory, non-current8,848 10,296 Total inventory$10,205 $11,490",
    "numberofoperatingsegments": 1,
    "numberofreportablesegments": 1,
    "numberofproductsinportfolio": 3,
    "restrictedcashandcashequivalents": 469000,
    "percentageofresponsibilityforpatientscostofbrandedprescriptionundermedicarepartd": 0.7,
    "advertisingexpense": 500000,
    "concentrationriskpercentage1": 0.2,
    "valuationallowancesandreservesbalance": 5211000,
    "valuationallowancesandreserveschargedtocostandexpense": 3001000,
    "valuationallowancesandreservesdeductions": 2934000,
    "assetacquisitiontransactioncostcurrent": 4200000,
    "debtsecuritiesavailableforsaleamortizedcostexcludingaccruedinterestafterallowanceforcreditlosscurrent": 185168000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 227000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 280000,
    "assetsfairvaluedisclosure": 209103000,
    "inventoryworkinprocessnetofreserves": 27000,
    "inventoryfinishedgoodsnetofreserves": 1330000,
    "inventoryrawmaterialsnetofreservesnoncurrent": 934000,
    "inventoryworkinprocessnetofreservesnoncurrent": 7177000,
    "inventoryfinishedgoodsnetofreservesnoncurrent": 737000,
    "inventorynoncurrent": 8848000,
    "inventory": 10205000,
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentgross": 6284000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 11181000,
    "areaofrealestateproperty": 33534,
    "operatingleasecost": 2200000,
    "shorttermleasecost": 400000,
    "operatingleasenonleasecomponentexpense": 1400000,
    "operatingleasepayments": 2700000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent",
    "operatingleaseliabilitycurrent": 2398000,
    "operatingleaseliability": 9404000,
    "operatingleaseweightedaverageremainingleaseterm1": "P4Y3M18D",
    "operatingleaseweightedaveragediscountratepercent": 0.082,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 2726000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 2796000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 2410000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 2159000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 1099000,
    "lesseeoperatingleaseliabilitypaymentsdue": 11190000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 1786000,
    "paymentstoacquireintangibleassets": 37500000,
    "finitelivedintangibleassetsgross": 33000000,
    "finitelivedintangibleassetsaccumulatedamortization": 15937000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 1463000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 1463000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1463000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 1463000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 1463000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 9748000,
    "accruedresearchanddevelopmentexpense": 15691000,
    "employeerelatedliabilitiescurrent": 6413000,
    "accruedprofessionalfeescurrent": 4404000,
    "accruedroyaltiescurrent": 2409000,
    "accountspayableandotheraccruedliabilitiescurrent": 7145000,
    "finitelivedintangibleassetsperiodincreasedecrease": 33000000,
    "royaltyperiod": "P10Y",
    "royaltypayableonnetsalespercentage": 0.05,
    "percentageoffuturesublicensefeespayable": "mid-twenties",
    "futurepercentageofroyaltypaymentsbasedonnetsales": "low double digits",
    "developmentandmilestoneobligationspaidtothirdparty": 2000000,
    "developmentandmilestonepaymentspotentiallyduetothirdparty": 10000000,
    "tieredroyaltiespayableonfuturenetsales": "single-digit",
    "agreementsforclinicalandmarketingservicesterminationnoticeperiod": "P90D",
    "accumulatedothercomprehensiveincomelossforeigncurrencytranslationadjustmentnetoftax": 21000,
    "accumulatedothercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -51000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsandrestrictedstockunitsrsuoutstandingnumber": 6697816,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 13790000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 4537290,
    "sharebasedcompensationoptionawardscontractualterm": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentannualawardvestingperiodemployeesandnewdirectors": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofsharesubjecttooptionawards": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardremainingpercentageofsharesubjecttooptionawards": 0.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestingperiodnumberofequalmonthlyinstallments": 36,
    "sharebasedcompensationarrangementbysharebasedpaymentawardserviceoptionawardsfullaccelerationofvestinginvoluntaryterminationperiodpostchangeofcontrol": "P24M",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 6000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.53,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 4792506,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 944776,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 384480,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 3292951,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 4642322,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 12.95,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 6.92,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 11.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 14.47,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 13.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P4Y9M14D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P5Y10M24D",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 13800000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 6.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 11300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1905310,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 868243,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 127744,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 750735,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 10.87,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 12.82,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 15.04,
    "allocatedsharebasedcompensationexpense": 3323000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsweightedaveragevolatilityrate": 0.47,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y1M28D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0389,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.5,
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 0.06,
    "definedcontributionplanvestingperiod": "P4Y",
    "definedcontributionplancostrecognized": 1000000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": 6184000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 155000,
    "currentfederaltaxexpensebenefit": 2577000,
    "currentstateandlocaltaxexpensebenefit": 2447000,
    "currentforeigntaxexpensebenefit": 91000,
    "deferredfederalincometaxexpensebenefit": -2240000,
    "deferredstateandlocalincometaxexpensebenefit": 970000,
    "deferredforeignincometaxexpensebenefit": -15000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.05,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.226,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.693,
    "effectiveincometaxratereconciliationtaxcreditsorphandrug": -0.045,
    "effectiveincometaxratereconciliationotheradjustments": 0.172,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": -0.234,
    "effectiveincometaxratereconciliationchangeinstatedeferredtaxespercent": 0.127,
    "effectiveincometaxratereconciliationuncertaintaxpositionspercent": 0.41,
    "effectiveincometaxratereconciliationsharebasedcompensationexcesstaxbenefitpercent": 0.302,
    "effectiveincometaxratereconciliationtaxsettlements": 0.027,
    "effectiveincometaxratereconciliationnondeductibleexpensemealsandentertainment": 0.055,
    "effectiveincometaxratereconciliationnondeductibleexpenseother": -0.003,
    "effectiveincometaxratecontinuingoperations": 0.604,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 5897000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefits": 4187000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 1453000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsallowancefordoubtfulaccounts": 1748000,
    "deferredtaxassetstaxcreditcarryforwardsresearchandother": 38559000,
    "deferredtaxassetscapitalizedresearchanddevelopmentcosts": 29036000,
    "deferredtaxassetstaxdeferredexpenseother": 5037000,
    "deferredtaxassetsgross": 85917000,
    "deferredtaxliabilitiesgoodwillandintangibleassetsintangibleassets": 812000,
    "deferredtaxliabilitiesother": 1558000,
    "deferredincometaxliabilities": 2370000,
    "deferredtaxassetsliabilitiesbeforevaluationallowancenet": 83547000,
    "deferredtaxassetsvaluationallowance": 8547000,
    "deferredtaxassetsnet": 75000000,
    "deferredtaxassetsvaluationallowanceincrease": 1411000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 16100000,
    "deferredtaxassetsliabilitiesnet": 22500000,
    "researchanddevelopmentcreditbeginningexpirationyear": 2031,
    "orphandrugcreditbeginningexpirationyear": 2030,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 5900000,
    "operatinglosscarryforwardsbeginningexpirationyear": 2032,
    "incometaxespaidnet": 3600000,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 18300000,
    "unrecognizedtaxbenefits": 18312000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 919000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 2003000,
    "unrecognizedtaxbenefitsreductionsresultingfromlapseofapplicablestatuteoflimitations": 95000,
    "weightedaveragenumberdilutedsharesoutstandingadjustment": 176936,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 6464057
  },
  {
    "date": "2022-12-30",
    "symbol": "VNDA",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "December 31, 2022",
    "currentfiscalyearenddate": "December 31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-34186",
    "entityregistrantname": "VANDA PHARMACEUTICALS INC.",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "03-0491827",
    "entityaddressaddressline1": "2200 Pennsylvania Avenue NW",
    "entityaddressaddressline2": "Suite 300 E",
    "entityaddresscityortown": "Washington",
    "entityaddressstateorprovince": "DC",
    "entityaddresspostalzipcode": 20037,
    "cityareacode": 202,
    "localphonenumber": "734-3400",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "VNDA",
    "securityexchangename": "The Nasdaq Global Market",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large accelerated filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "amendmentflag": "FALSE",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entitycentralindexkey": 1347178,
    "auditorfirmid": 238,
    "auditorname": "PricewaterhouseCoopers LLP",
    "auditorlocation": "Baltimore, Maryland",
    "cashandcashequivalentsatcarryingvalue": 135029000,
    "debtsecuritiesavailableforsaleexcludingaccruedinterestcurrent": 154660000,
    "accountsreceivablenetcurrent": 33512000,
    "inventorynet": 1194000,
    "prepaidexpenseandotherassetscurrent": 17727000,
    "assetscurrent": 519292000,
    "propertyplantandequipmentnet": 2573000,
    "operatingleaserightofuseasset": 8400000,
    "finitelivedintangibleassetsnet": 18565000,
    "deferredincometaxassetsnet": 74039000,
    "inventoryandothernoncurrent": 11378000,
    "assets": 634247000,
    "accountspayableandaccruedliabilitiescurrent": 45551000,
    "productrevenueallowancescurrent": 45885000,
    "liabilitiescurrent": 91436000,
    "operatingleaseliabilitynoncurrent": 8813000,
    "otherliabilitiesnoncurrent": 6800000,
    "liabilities": 107049000,
    "commonstockvalue": 57000,
    "additionalpaidincapitalcommonstock": 686235000,
    "accumulatedothercomprehensiveincomelossnetoftax": -1193000,
    "retainedearningsaccumulateddeficit": -157901000,
    "stockholdersequity": -157901000,
    "liabilitiesandstockholdersequity": 634247000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 20000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 150000000,
    "commonstocksharesissued": 56783764,
    "commonstocksharesoutstanding": 56783764,
    "revenuefromcontractwithcustomerexcludingassessedtax": 94727000,
    "revenues": 254382000,
    "costofgoodsandserviceexcludingdepreciationdepletionandamortization": 24282000,
    "researchanddevelopmentexpense": 85770000,
    "sellinggeneralandadministrativeexpense": 136485000,
    "amortizationofintangibleassets": 1516000,
    "costsandexpenses": 248053000,
    "operatingincomeloss": 6329000,
    "otherincome": 4971000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": 11300000,
    "incometaxexpensebenefit": 5025000,
    "netincomeloss": 6275000,
    "earningspersharebasic": 0.11,
    "earningspersharediluted": 0.11,
    "weightedaveragenumberofsharesoutstandingbasic": 56461877,
    "weightedaveragenumberofdilutedsharesoutstanding": 56983171,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentbeforetax": -39000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentbeforetax": -1271000,
    "othercomprehensiveincomelosstax": -292000,
    "othercomprehensiveincomelossnetoftax": -1018000,
    "comprehensiveincomenetoftax": 5257000,
    "stockissuedduringperiodsharessharebasedcompensation": 882909,
    "stockissuedduringperiodvaluesharebasedcompensation": 734000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 16279000,
    "depreciation": 1217000,
    "sharebasedcompensation": 16279000,
    "investmentincomenetamortizationofdiscountandpremium": 2963000,
    "deferredincometaxexpensebenefit": 1130000,
    "othernoncashincomeexpense": -2456000,
    "increasedecreaseinaccountsreceivable": 1089000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 6136000,
    "increasedecreaseininventories": 4479000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 11793000,
    "increasedecreaseproductrevenueallowances": 5985000,
    "netcashprovidedbyusedinoperatingactivities": 31984000,
    "paymentstoacquirepropertyplantandequipment": 679000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 349258000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 399862000,
    "netcashprovidedbyusedininvestingactivities": 49925000,
    "proceedsfromstockoptionsexercised": 734000,
    "netcashprovidedbyusedinfinancingactivities": 734000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": 265000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 82908000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 135498000,
    "numberofoperatingsegments": 1,
    "numberofproductsinportfolio": 2,
    "restrictedcashandcashequivalents": 469000,
    "concentrationriskpercentage1": 0.14,
    "percentageofresponsibilityforpatientscostofbrandedprescriptionundermedicarepartd": 0.7000000000000001,
    "advertisingexpense": 2600000,
    "numberofreportablesegments": 1,
    "valuationallowancesandreservesbalance": 5144000,
    "valuationallowancesandreserveschargedtocostandexpense": 4332000,
    "valuationallowancesandreservesdeductions": 3739000,
    "debtsecuritiesavailableforsaleamortizedcostexcludingaccruedinterestafterallowanceforcreditlosscurrent": 333368000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 14000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 1552000,
    "assetsfairvaluedisclosure": 154660000,
    "inventoryworkinprocessnetofreserves": 23000,
    "inventoryfinishedgoodsnetofreserves": 1171000,
    "inventoryrawmaterialsnetofreservesnoncurrent": 1043000,
    "inventoryworkinprocessnetofreservesnoncurrent": 8212000,
    "inventoryfinishedgoodsnetofreservesnoncurrent": 1041000,
    "inventorynoncurrent": 10296000,
    "inventory": 11490000,
    "propertyplantandequipmentusefullife": 11,
    "propertyplantandequipmentgross": 12992000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 10419000,
    "areaofrealestateproperty": 2880,
    "lesseeoperatingleaserenewalterm": "five years",
    "operatingleasecost": 2200000,
    "shorttermleasecost": 400000,
    "operatingleasenonleasecomponentexpense": 1400000,
    "operatingleasepayments": 2600000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#AccountsPayableAndAccruedLiabilitiesCurrent",
    "operatingleaseliabilitycurrent": 2328000,
    "operatingleaseliability": 11141000,
    "operatingleaseweightedaverageremainingleaseterm1": 5.2,
    "operatingleaseweightedaveragediscountratepercent": 0.08199999999999999,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 2647000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 2714000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 2784000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 2407000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 2159000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 1099000,
    "lesseeoperatingleaseliabilitypaymentsdue": 13810000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 2669000,
    "paymentstoacquireintangibleassets": 37500000,
    "finitelivedintangibleassetsgross": 27900000,
    "finitelivedintangibleassetsaccumulatedamortization": 14435000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 1516000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 1516000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1516000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 1516000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 1516000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 10985000,
    "employeerelatedliabilitiescurrent": 6839000,
    "accruedresearchanddevelopmentexpense": 9474000,
    "accruedroyaltiescurrent": 4979000,
    "accruedprofessionalfeescurrent": 9241000,
    "accountspayableandotheraccruedliabilitiescurrent": 12690000,
    "finitelivedintangibleassetsperiodincreasedecrease": 33000000,
    "royaltyperiod": 10,
    "royaltypayableonnetsalespercentage": 0.06,
    "percentageoffuturesublicensefeespayable": "mid-twenties",
    "futurepercentageofroyaltypaymentsbasedonnetsales": "mid-teens",
    "developmentandmilestonepaymentspotentiallyduetothirdparty": 3200000,
    "tieredroyaltiespayableonfuturenetsales": "single-digit",
    "agreementsforclinicalandmarketingservicesterminationnoticeperiod": 90,
    "accumulatedothercomprehensiveincomelossforeigncurrencytranslationadjustmentnetoftax": -7000,
    "accumulatedothercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -1186000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsandrestrictedstockunitsrsuoutstandingnumber": 6147756,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 11890000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 4257565,
    "sharebasedcompensationoptionawardscontractualterm": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentannualawardvestingperiodemployeesandnewdirectors": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofsharesubjecttooptionawards": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardremainingpercentageofsharesubjecttooptionawards": 0.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestingperiodnumberofequalmonthlyinstallments": 4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardserviceoptionawardsfullaccelerationofvestinginvoluntaryterminationperiodpostchangeofcontrol": 24,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 7100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 1.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.18,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 1600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 4232210,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 745028,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 14000,
    "stockissuedduringperiodsharesstockoptionsexercised": 219966,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2969040,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 4104620,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 14.19,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 11.1,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 11.95,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 3.34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 14.43,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 14.23,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 5.81,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 4.62,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 5.72,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 19100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 11.24,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 11600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1915546,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 944374,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 130625,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 662943,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 14.41,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 14.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 17.49,
    "allocatedsharebasedcompensationexpense": 16279000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsweightedaveragevolatilityrate": 0.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0203,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.5,
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 0.06,
    "definedcontributionplanvestingperiod": 4,
    "definedcontributionplancostrecognized": 1100000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": 11216000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 84000,
    "currentstateandlocaltaxexpensebenefit": 3710000,
    "currentforeigntaxexpensebenefit": 185000,
    "deferredfederalincometaxexpensebenefit": 1238000,
    "deferredstateandlocalincometaxexpensebenefit": -111000,
    "deferredforeignincometaxexpensebenefit": 3000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.048,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.01,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.259,
    "effectiveincometaxratereconciliationtaxcreditsorphandrug": -0.009000000000000001,
    "effectiveincometaxratereconciliationotheradjustments": 0.094,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.017,
    "effectiveincometaxratereconciliationuncertaintaxpositionspercent": 0.245,
    "effectiveincometaxratereconciliationsharebasedcompensationexcesstaxbenefitpercent": 0.057999999999999996,
    "effectiveincometaxratereconciliationtaxsettlements": 0.026000000000000002,
    "effectiveincometaxratereconciliationnondeductibleexpenseother": 0.005,
    "effectiveincometaxratecontinuingoperations": 0.445,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 6100000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefits": 4930000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 1469000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsallowancefordoubtfulaccounts": 1560000,
    "deferredtaxassetstaxcreditcarryforwardsresearchandother": 42402000,
    "deferredtaxassetscapitalizedresearchanddevelopmentcosts": 16990000,
    "deferredtaxassetstaxdeferredexpenseother": 3798000,
    "deferredtaxassetsgross": 84895000,
    "deferredtaxliabilitiesgoodwillandintangibleassetsintangibleassets": 1924000,
    "deferredtaxliabilitiesother": 1796000,
    "deferredincometaxliabilities": 3720000,
    "deferredtaxassetsliabilitiesbeforevaluationallowancenet": 81175000,
    "deferredtaxassetsvaluationallowance": 7136000,
    "deferredtaxassetsnet": 74039000,
    "deferredtaxassetsvaluationallowanceincrease": 111000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 17900000,
    "deferredtaxassetsliabilitiesnet": 24500000,
    "operatinglosscarryforwardsbeginningexpirationyear": 2029,
    "researchanddevelopmentcreditbeginningexpirationyear": 2024,
    "orphandrugcreditbeginningexpirationyear": 2030,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 7700000,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 15500000,
    "unrecognizedtaxbenefits": 15485000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 75000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 2895000,
    "unrecognizedtaxbenefitsdecreasesresultingfromsettlementswithtaxingauthorities": 270000,
    "weightedaveragenumberdilutedsharesoutstandingadjustment": 521294,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 4786891
  },
  {
    "date": "2021-12-30",
    "symbol": "VNDA",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "December 31, 2021",
    "currentfiscalyearenddate": "December 31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-34186",
    "entityregistrantname": "VANDA PHARMACEUTICALS INC.",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "03-0491827",
    "entityaddressaddressline1": "2200 Pennsylvania Avenue NW",
    "entityaddressaddressline2": "Suite 300 E",
    "entityaddresscityortown": "Washington",
    "entityaddressstateorprovince": "DC",
    "entityaddresspostalzipcode": 20037,
    "cityareacode": 202,
    "localphonenumber": "734-3400",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "VNDA",
    "securityexchangename": "The Nasdaq Global Market",
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large accelerated filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "amendmentflag": "FALSE",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entitycentralindexkey": 1347178,
    "auditorfirmid": 238,
    "auditorname": "PricewaterhouseCoopers LLP",
    "auditorlocation": "Baltimore, Maryland",
    "cashandcashequivalentsatcarryingvalue": 52071000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 380742000,
    "accountsreceivablenetcurrent": 32467000,
    "inventorynet": 1025000,
    "prepaidexpenseandotherassetscurrent": 11996000,
    "assetscurrent": 478301000,
    "propertyplantandequipmentnet": 3113000,
    "operatingleaserightofuseasset": 9272000,
    "finitelivedintangibleassetsnet": 20081000,
    "deferredincometaxassetsnet": 74878000,
    "inventoryandothernoncurrent": 8147000,
    "assets": 593792000,
    "accountspayableandaccruedliabilitiescurrent": 34438000,
    "productrevenueallowancescurrent": 39981000,
    "liabilitiescurrent": 74419000,
    "operatingleaseliabilitynoncurrent": 10055000,
    "otherliabilitiesnoncurrent": 4390000,
    "liabilities": 88864000,
    "commonstockvalue": 56000,
    "additionalpaidincapitalcommonstock": 669223000,
    "accumulatedothercomprehensiveincomelossnetoftax": -175000,
    "retainedearningsaccumulateddeficit": -164176000,
    "stockholdersequity": -164176000,
    "liabilitiesandstockholdersequity": 593792000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 20000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 150000000,
    "commonstocksharesissued": 55900855,
    "commonstocksharesoutstanding": 55900855,
    "revenuefromcontractwithcustomerexcludingassessedtax": 95146000,
    "revenues": 268682000,
    "costofgoodsandserviceexcludingdepreciationdepletionandamortization": 25629000,
    "researchanddevelopmentexpense": 75363000,
    "sellinggeneralandadministrativeexpense": 124047000,
    "amortizationofintangibleassets": 1478000,
    "costsandexpenses": 226517000,
    "operatingincomeloss": 42165000,
    "otherincome": 199000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": 42364000,
    "incometaxexpensebenefit": 9212000,
    "netincomeloss": 33152000,
    "earningspersharebasic": 0.6,
    "earningspersharediluted": 0.58,
    "weightedaveragenumberofsharesoutstandingbasic": 55548122,
    "weightedaveragenumberofdilutedsharesoutstanding": 56921836,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentbeforetax": -49000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentbeforetax": -472000,
    "othercomprehensiveincomelosstax": -107000,
    "othercomprehensiveincomelossnetoftax": -414000,
    "comprehensiveincomenetoftax": 32738000,
    "stockissuedduringperiodsharessharebasedcompensation": 1035763,
    "stockissuedduringperiodvaluesharebasedcompensation": 3550000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 15374000,
    "depreciation": 1363000,
    "sharebasedcompensation": 15374000,
    "investmentincomenetamortizationofdiscountandpremium": -1649000,
    "debtsecuritiesavailableforsalerealizedgainloss": 12000,
    "deferredincometaxexpensebenefit": 6745000,
    "othernoncashincomeexpense": -1728000,
    "increasedecreaseinaccountsreceivable": 2469000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 1247000,
    "increasedecreaseininventories": 2233000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 3040000,
    "increasedecreaseproductrevenueallowances": 5646000,
    "netcashprovidedbyusedinoperatingactivities": 64214000,
    "paymentstoacquirepropertyplantandequipment": 552000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 420461000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 344317000,
    "netcashprovidedbyusedininvestingactivities": -76696000,
    "proceedsfromstockoptionsexercised": 3550000,
    "netcashprovidedbyusedinfinancingactivities": 3550000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": -91000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -9023000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 52590000,
    "numberofoperatingsegments": 1,
    "numberofproductsinportfolio": 2,
    "restrictedcashandcashequivalents": 519000,
    "concentrationriskpercentage1": 0.14,
    "percentageofresponsibilityforpatientscostofbrandedprescriptionundermedicarepartd": 0.7000000000000001,
    "advertisingexpense": 6700000,
    "numberofreportablesegments": 1,
    "valuationallowancesandreservesbalance": 4551000,
    "valuationallowancesandreserveschargedtocostandexpense": 2870000,
    "valuationallowancesandreservesdeductions": 3017000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 381009000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 114000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 381000,
    "availableforsalesecuritiesdebtsecurities": 380742000,
    "assetsfairvaluedisclosure": 186023000,
    "inventoryworkinprocessnetofreserves": 30000,
    "inventoryfinishedgoodsnetofreserves": 995000,
    "inventoryrawmaterialsnetofreservesnoncurrent": 2143000,
    "inventoryworkinprocessnetofreservesnoncurrent": 3934000,
    "inventoryfinishedgoodsnetofreservesnoncurrent": 1150000,
    "inventorynoncurrent": 7227000,
    "inventory": 8252000,
    "propertyplantandequipmentusefullife": 11,
    "propertyplantandequipmentgross": 12490000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 9377000,
    "areaofrealestateproperty": 2880,
    "lesseeoperatingleaserenewalterm": "three years",
    "operatingleasecost": 2300000,
    "shorttermleasecost": 400000,
    "operatingleasenonleasecomponentexpense": 1400000,
    "operatingleasepayments": 2300000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#AccountsPayableAndAccruedLiabilitiesCurrent",
    "operatingleaseliabilitycurrent": 2311000,
    "operatingleaseliability": 12366000,
    "operatingleaseweightedaverageremainingleaseterm1": 6.2,
    "operatingleaseweightedaveragediscountratepercent": 0.081,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 2608000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 2461000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 2488000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 2557000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 2366000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 3258000,
    "lesseeoperatingleaseliabilitypaymentsdue": 15738000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 3372000,
    "paymentstoacquireintangibleassets": 37500000,
    "finitelivedintangibleassetsperiodincreasedecrease": 33000000,
    "finitelivedintangibleassetsgross": 27900000,
    "finitelivedintangibleassetsaccumulatedamortization": 12919000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 1478000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 1478000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1478000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 1478000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 1478000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 12691000,
    "employeerelatedliabilitiescurrent": 6515000,
    "accruedresearchanddevelopmentexpense": 10082000,
    "accruedroyaltiescurrent": 5873000,
    "accruedprofessionalfeescurrent": 8732000,
    "accountspayableandotheraccruedliabilitiescurrent": 925000,
    "royaltyperiod": 10,
    "royaltypayableonnetsalespercentage": 0.06,
    "percentageoffuturesublicensefeespayable": "mid-twenties",
    "futurepercentageofroyaltypaymentsbasedonnetsales": "mid-teens",
    "developmentandmilestonepaymentspotentiallyduetothirdparty": 3200000,
    "tieredroyaltiespayableonfuturenetsales": "single-digit",
    "agreementsforclinicalandmarketingservicesterminationnoticeperiod": 90,
    "accumulatedothercomprehensiveincomelossforeigncurrencytranslationadjustmentnetoftax": 32000,
    "accumulatedothercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -207000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsandrestrictedstockunitsrsuoutstandingnumber": 5485888,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 10790000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 4716342,
    "sharebasedcompensationoptionawardscontractualterm": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentannualawardvestingperiodemployeesandnewdirectors": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofsharesubjecttooptionawards": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardremainingpercentageofsharesubjecttooptionawards": 0.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestingperiodnumberofequalmonthlyinstallments": 4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardserviceoptionawardsfullaccelerationofvestinginvoluntaryterminationperiodpostchangeofcontrol": 24,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 7900000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 1.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 8.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 4099999.9999999995,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 3721148,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 708500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 128285,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 10000,
    "stockissuedduringperiodsharesstockoptionsexercised": 455885,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2616440,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 3604678,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 14.16,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 20.2,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 15.79,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 18.3,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 7.79,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 12.69,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 14.03,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 5.77,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 4.56,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 5.67,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 11327000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 10045000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 11215000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 22000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 19.57,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 9100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1764740,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 899305,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 194250,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 579878,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 17.27,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 15.54,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 15.73,
    "allocatedsharebasedcompensationexpense": 15374000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsweightedaveragevolatilityrate": 0.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 5.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0075,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.5,
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 0.06,
    "definedcontributionplanvestingperiod": 4,
    "definedcontributionplancostrecognized": 1000000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": 42221000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 143000,
    "currentstateandlocaltaxexpensebenefit": 2200000,
    "currentforeigntaxexpensebenefit": 267000,
    "deferredfederalincometaxexpensebenefit": 6604000,
    "deferredstateandlocalincometaxexpensebenefit": 119000,
    "deferredforeignincometaxexpensebenefit": 22000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.023,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.001,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.065,
    "effectiveincometaxratereconciliationtaxcreditsorphandrug": -0.001,
    "effectiveincometaxratereconciliationotheradjustments": 0.026000000000000002,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": -0.002,
    "effectiveincometaxratereconciliationuncertaintaxpositionspercent": 0.04,
    "effectiveincometaxratereconciliationsharebasedcompensationexcesstaxbenefitpercent": -0.018000000000000002,
    "effectiveincometaxratereconciliationnondeductibleexpenseother": 0.005,
    "effectiveincometaxratecontinuingoperations": 0.217,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 27200000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefits": 4846000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 1409000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsallowancefordoubtfulaccounts": 1142000,
    "deferredtaxassetstaxcreditcarryforwardsresearchandother": 39975000,
    "deferredtaxassetstaxdeferredexpenseother": 3081000,
    "deferredtaxassetsgross": 85962000,
    "deferredtaxliabilitiesgoodwillandintangibleassetsintangibleassets": 1919000,
    "deferredtaxliabilitiesother": 2140000,
    "deferredincometaxliabilities": 4059000,
    "deferredtaxassetsliabilitiesbeforevaluationallowancenet": 81903000,
    "deferredtaxassetsvaluationallowance": 7025000,
    "deferredtaxassetsnet": 74878000,
    "deferredtaxassetsvaluationallowancedecrease": 26000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 15500000,
    "deferredtaxassetsliabilitiesnet": 24400000,
    "operatinglosscarryforwardsbeginningexpirationyear": 2029,
    "researchanddevelopmentcreditbeginningexpirationyear": 2024,
    "orphandrugcreditbeginningexpirationyear": 2030,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 8300000.000000001,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 12900000,
    "unrecognizedtaxbenefits": 12935000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 122000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1580000,
    "weightedaveragenumberdilutedsharesoutstandingadjustment": 1373714,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 2176944
  },
  {
    "date": "2020-12-30",
    "symbol": "VNDA",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2020-12-31",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-34186",
    "entityregistrantname": "VANDA PHARMACEUTICALS INC.",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "03-0491827",
    "entityaddressaddressline1": "2200 Pennsylvania Avenue NW",
    "entityaddressaddressline2": "Suite 300 E",
    "entityaddresscityortown": "Washington",
    "entityaddressstateorprovince": "DC",
    "entityaddresspostalzipcode": 20037,
    "cityareacode": 202,
    "localphonenumber": "734-3400",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "VNDA",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "amendmentflag": "false",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "entitycentralindexkey": 1347178,
    "cashandcashequivalentsatcarryingvalue": 61031000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 306709000,
    "accountsreceivablenetcurrent": 30036000,
    "inventorynet": 1280000,
    "prepaidexpenseandotherassetscurrent": 10089000,
    "assetscurrent": 409145000,
    "propertyplantandequipmentnet": 4136000,
    "operatingleaserightofuseasset": 10459000,
    "finitelivedintangibleassetsnet": 21559000,
    "deferredincometaxassetsnet": 81516000,
    "inventoryandothernoncurrent": 6641000,
    "assets": 533456000,
    "accountspayableandaccruedliabilitiescurrent": 31509000,
    "productrevenueallowancescurrent": 34427000,
    "liabilitiescurrent": 65936000,
    "operatingleaseliabilitynoncurrent": 11497000,
    "otherliabilitiesnoncurrent": 2757000,
    "liabilities": 80190000,
    "commonstockvalue": 55000,
    "additionalpaidincapitalcommonstock": 650300000,
    "accumulatedothercomprehensiveincomelossnetoftax": 239000,
    "retainedearningsaccumulateddeficit": -197328000,
    "stockholdersequity": 453266000,
    "liabilitiesandstockholdersequity": 533456000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 20000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 150000000,
    "commonstocksharesissued": 54865092,
    "commonstocksharesoutstanding": 54865092,
    "revenuefromcontractwithcustomerexcludingassessedtax": 248168000,
    "revenues": 248168000,
    "costofgoodsandserviceexcludingdepreciationdepletionandamortization": 23364000,
    "researchanddevelopmentexpense": 55577000,
    "sellinggeneralandadministrativeexpense": 140510000,
    "amortizationofintangibleassets": 1478000,
    "costsandexpenses": 220929000,
    "operatingincomeloss": 27239000,
    "otherincome": 4416000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": 31655000,
    "incometaxexpensebenefit": 8318000,
    "netincomeloss": 23337000,
    "earningspersharebasic": 0.43,
    "earningspersharediluted": 0.42,
    "weightedaveragenumberofsharesoutstandingbasic": 54427683,
    "weightedaveragenumberofdilutedsharesoutstanding": 55190802,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentbeforetax": 68000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentbeforetax": -102000,
    "othercomprehensiveincomelosstax": -24000,
    "othercomprehensiveincomelossnetoftax": -10000,
    "comprehensiveincomenetoftax": 23327000,
    "stockissuedduringperiodvaluesharebasedcompensation": 1000,
    "stockissuedduringperiodsharessharebasedcompensation": 1315480,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 13360000,
    "depreciation": 1386000,
    "sharebasedcompensation": 13360000,
    "investmentincomenetamortizationofdiscountandpremium": -179000,
    "debtsecuritiesavailableforsalerealizedgainloss": 229000,
    "deferredincometaxexpensebenefit": 6189000,
    "othernoncashincomeexpense": -1758000,
    "increasedecreaseinaccountsreceivable": 3767000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -4068000,
    "increasedecreaseininventories": 2876000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 3759000,
    "increasedecreaseproductrevenueallowances": 3133000,
    "netcashprovidedbyusedinoperatingactivities": 51775000,
    "paymentstoacquireintangibleassets": 37500000,
    "paymentstoacquirepropertyplantandequipment": 1795000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 346622000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 306918000,
    "netcashprovidedbyusedininvestingactivities": -41499000,
    "proceedsfromstockoptionsexercised": 5634000,
    "netcashprovidedbyusedinfinancingactivities": 5634000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": 53000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 15963000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 61613000,
    "numberofoperatingsegments": 1,
    "numberofproductsinportfolio": 2,
    "restrictedcashandcashequivalents": 57000,
    "concentrationriskpercentage1": 0.43,
    "percentageofresponsibilityforpatientscostofbrandedprescriptionundermedicarepartd": 0.7,
    "advertisingexpense": 12600000,
    "numberofreportablesegments": 1,
    "valuationallowancesandreservesbalance": 4698000,
    "valuationallowancesandreserveschargedtocostandexpense": 3844000,
    "valuationallowancesandreservesdeductions": 5266000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 165966000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 129000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 3000,
    "availableforsalesecuritiesdebtsecurities": 166092000,
    "assetsfairvaluedisclosure": 166092000,
    "inventoryworkinprocessnetofreserves": 66000,
    "inventoryfinishedgoodsnetofreserves": 1214000,
    "inventoryrawmaterialsnetofreservesnoncurrent": 744000,
    "inventoryworkinprocessnetofreservesnoncurrent": 4045000,
    "inventoryfinishedgoodsnetofreservesnoncurrent": 302000,
    "inventorynoncurrent": 5091000,
    "inventory": 6371000,
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentgross": 5212000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 8028000,
    "areaofrealestateproperty": 33534,
    "lesseeoperatingleaserenewalterm": "P5Y",
    "operatingleasecost": 2300000,
    "shorttermleasecost": 400000,
    "operatingleasenonleasecomponentexpense": 1500000,
    "operatingleasepayments": 2600000,
    "operatingleaseliabilitycurrent": 2117000,
    "operatingleaseliability": 13614000,
    "operatingleaseweightedaverageremainingleaseterm1": "P7Y1M6D",
    "operatingleaseweightedaveragediscountratepercent": 0.081,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 2290000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 2611000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 2462000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 2488000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 2557000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 5624000,
    "lesseeoperatingleaseliabilitypaymentsdue": 18032000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 4418000,
    "finitelivedintangibleassetsperiodincreasedecrease": 33000000,
    "finitelivedintangibleassetsgross": 33000000,
    "finitelivedintangibleassetsaccumulatedamortization": 11441000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 1478000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 1478000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1478000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 1478000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 1478000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 14169000,
    "employeerelatedliabilitiescurrent": 10951000,
    "accruedresearchanddevelopmentexpense": 6173000,
    "accruedroyaltiescurrent": 5817000,
    "accruedprofessionalfeescurrent": 5052000,
    "accruedmilestoneobligationsunderlicenseagreements": 350000,
    "otheraccruedliabilitiescurrent": 1049000,
    "royaltyperiod": "P10Y",
    "royaltypayableonnetsalespercentage": 0.1,
    "percentageoffuturesublicensefeespayable": "mid-twenties",
    "futurepercentageofroyaltypaymentsbasedonnetsales": "low double digits",
    "developmentandmilestonepaymentspotentiallyduetothirdparty": 2000000,
    "tieredroyaltiespayableonfuturenetsales": "single-digit",
    "agreementsforclinicalandmarketingservicesterminationnoticeperiod": "P90D",
    "accumulatedothercomprehensiveincomelossforeigncurrencytranslationadjustmentnetoftax": 81000,
    "accumulatedothercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 158000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsandrestrictedstockunitsrsuoutstandingnumber": 5246381,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 8790000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 3991612,
    "sharebasedcompensationoptionawardscontractualterm": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentannualawardvestingperiodemployeesandnewdirectors": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofsharesubjecttooptionawards": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardremainingpercentageofsharesubjecttooptionawards": 0.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestingperiodnumberofequalmonthlyinstallments": 36,
    "sharebasedcompensationarrangementbysharebasedpaymentawardserviceoptionawardsfullaccelerationofvestinginvoluntaryterminationperiodpostchangeofcontrol": "P24M",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 6900000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.53,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 18300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 581757,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 9600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 3606818,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 627500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 225000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 557604,
    "stockissuedduringperiodsharesstockoptionsexercised": 733223,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2556394,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 3482804,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 12.24,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 11.27,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 18.83,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 14.21,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 7.68,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 11.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 12.22,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P5Y9M3D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P4Y6M10D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P5Y7M20D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 8511000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 2868000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 7302000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 8337000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1639563,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 832162,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 260127,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 15.26,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 11.28,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 17.35,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 16.54,
    "allocatedsharebasedcompensationexpense": 3804000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsweightedaveragevolatilityrate": 0.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y25D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0114,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.5,
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 0.06,
    "definedcontributionplanvestingperiod": "P4Y",
    "definedcontributionplancostrecognized": 900000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": 31667000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -12000,
    "currentstateandlocaltaxexpensebenefit": 2061000,
    "currentforeigntaxexpensebenefit": 68000,
    "deferredfederalincometaxexpensebenefit": 6076000,
    "deferredstateandlocalincometaxexpensebenefit": 155000,
    "deferredforeignincometaxexpensebenefit": -42000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.026,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.035,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.054,
    "effectiveincometaxratereconciliationtaxcreditsorphandrug": -0.013,
    "effectiveincometaxratereconciliationotheradjustments": 0.017,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.002,
    "effectiveincometaxratereconciliationuncertaintaxpositionspercent": 0.047,
    "effectiveincometaxratereconciliationsharebasedcompensationexcesstaxbenefitpercent": 0.051,
    "effectiveincometaxratereconciliationnondeductibleexpenseother": 0.012,
    "effectiveincometaxratecontinuingoperations": 0.263,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 43623000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefits": 4653000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 2429000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsallowancefordoubtfulaccounts": 1169000,
    "deferredtaxassetstaxcreditcarryforwardsresearchandother": 37737000,
    "deferredtaxassetstaxdeferredexpenseother": 3279000,
    "deferredtaxassetsgross": 92890000,
    "deferredtaxliabilitiesgoodwillandintangibleassetsintangibleassets": 1911000,
    "deferredtaxliabilitiesother": 2412000,
    "deferredincometaxliabilities": 4323000,
    "deferredtaxassetsliabilitiesbeforevaluationallowancenet": 88567000,
    "deferredtaxassetsvaluationallowance": 7051000,
    "deferredtaxassetsnet": 81516000,
    "deferredtaxassetsvaluationallowancedecrease": 1104000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 13400000,
    "deferredtaxassetsliabilitiesnet": 24400000,
    "operatinglosscarryforwardsbeginningexpirationyear": 2031,
    "researchanddevelopmentcreditbeginningexpirationyear": 2024,
    "orphandrugcreditbeginningexpirationyear": 2030,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 8400000,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 11200000,
    "unrecognizedtaxbenefits": 11233000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 121000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1613000,
    "weightedaveragenumberdilutedsharesoutstandingadjustment": 763119,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 3407409
  },
  {
    "date": "2019-12-30",
    "symbol": "VNDA",
    "period": "FY",
    "employeerelatedliabilitiescurrent": 6597000,
    "accruedroyaltiescurrent": 5904000,
    "accruedresearchanddevelopmentexpense": 5893000,
    "accruedprofessionalfeescurrent": 5376000,
    "operatingleaseliabilitycurrent": 2147000,
    "otheraccruedliabilitiescurrent": 1673000,
    "accountspayableandaccruedliabilitiescurrent": 27590000,
    "accumulatedothercomprehensiveincomelossforeigncurrencytranslationadjustmentnetoftax": 13000,
    "accumulatedothercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 236000,
    "accumulatedothercomprehensiveincomelossnetoftax": 249000,
    "numberofoperatingsegments": 1,
    "numberofproductsinportfolio": 2,
    "developmentandmilestonepaymentspotentiallyduetothirdparty": 10000000,
    "tieredroyaltiespayableonfuturenetsales": "single-digit",
    "developmentandmilestoneobligationspaidtothirdparty": 3000000,
    "royaltypayableonnetsalespercentage": 0.1,
    "royaltyperiod": "P10Y",
    "paymentstoacquireintangibleassets": 37500000,
    "finitelivedintangibleassetsperiodincreasedecrease": 33000000,
    "percentageoffuturesublicensefeespayable": "mid-twenties",
    "agreementsforclinicalandmarketingservicesterminationnoticeperiod": "P90D",
    "purchaseobligationdueinnexttwelvemonths": 9200000,
    "purchaseobligationdueinsecondyear": 1000000,
    "purchaseobligationdueinthirdyear": 500000,
    "futurepercentageofroyaltypaymentsbasedonnetsales": "low double digits",
    "milestoneobligationunderlicenseagreement": 2000000,
    "cashandcashequivalentsatcarryingvalue": 45072000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 267057000,
    "accountsreceivablenetcurrent": 26367000,
    "inventorynet": 1140000,
    "prepaidexpenseandotherassetscurrent": 14500000,
    "assetscurrent": 354136000,
    "propertyplantandequipmentnet": 3864000,
    "operatingleaserightofuseasset": 11180000,
    "finitelivedintangibleassetsnet": 23037000,
    "deferredincometaxassetsnet": 87680000,
    "inventoryandothernoncurrent": 3851000,
    "assets": 483748000,
    "productrevenueallowancescurrent": 31915000,
    "liabilitiescurrent": 59505000,
    "operatingleaseliabilitynoncurrent": 12455000,
    "otherliabilitiesnoncurrent": 843000,
    "liabilities": 72803000,
    "commonstockvalue": 54000,
    "additionalpaidincapitalcommonstock": 631307000,
    "retainedearningsaccumulateddeficit": -220665000,
    "stockholdersequity": 410945000,
    "liabilitiesandstockholdersequity": 483748000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 20000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 150000000,
    "commonstocksharesissued": 53549612,
    "commonstocksharesoutstanding": 53549612,
    "netincomeloss": 115553000,
    "depreciation": 1387000,
    "sharebasedcompensation": 13458000,
    "investmentincomenetamortizationofdiscountandpremium": 3099000,
    "amortizationofintangibleassets": 1505000,
    "deferredincometaxexpensebenefit": -87767000,
    "othernoncashincomeexpense": -1785000,
    "increasedecreaseinaccountsreceivable": -2342000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 2764000,
    "increasedecreaseininventories": 722000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 3508000,
    "increasedecreaseproductrevenueallowances": 761000,
    "netcashprovidedbyusedinoperatingactivities": 45947000,
    "paymentstoacquirepropertyplantandequipment": 1019000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 394517000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 327227000,
    "netcashprovidedbyusedininvestingactivities": -68309000,
    "proceedsfromstockoptionsexercised": 6264000,
    "netcashprovidedbyusedinfinancingactivities": 6264000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": -1000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -16099000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 45650000,
    "stockissuedduringperiodvaluesharebasedcompensation": 2000,
    "stockissuedduringperiodsharessharebasedcompensation": 1072019,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 13458000,
    "othercomprehensiveincomelossnetoftax": 248000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentbeforetax": 6000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentbeforetax": 313000,
    "othercomprehensiveincomelosstax": 71000,
    "comprehensiveincomenetoftax": 115801000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 227188000,
    "revenues": 227188000,
    "costofgoodssoldexcludingdepreciationdepletionandamortization": 24488000,
    "researchanddevelopmentexpense": 48649000,
    "sellinggeneralandadministrativeexpense": 129736000,
    "costsandexpenses": 204378000,
    "operatingincomeloss": 22810000,
    "otherincome": 6218000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": 29028000,
    "incometaxexpensebenefit": -86525000,
    "earningspersharebasic": 2.17,
    "earningspersharediluted": 2.11,
    "weightedaveragenumberofsharesoutstandingbasic": 53137562,
    "weightedaveragenumberofdilutedsharesoutstanding": 54847060,
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2019-12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-34186",
    "entityregistrantname": "VANDA PHARMACEUTICALS INC.",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "03-0491827",
    "entityaddressaddressline1": "2200 Pennsylvania Avenue NW",
    "entityaddressaddressline2": "Suite 300 E",
    "entityaddresscityortown": "Washington",
    "entityaddressstateorprovince": "DC",
    "entityaddresspostalzipcode": 20037,
    "cityareacode": 202,
    "localphonenumber": "734-3400",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "VNDA",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "amendmentflag": "false",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "entitycentralindexkey": 1347178,
    "currentfiscalyearenddate": "--12-31",
    "weightedaveragenumberdilutedsharesoutstandingadjustment": 1709498,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1932024,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.5,
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 0.06,
    "definedcontributionplanvestingperiod": "P4Y",
    "definedcontributionplancostrecognized": 800000,
    "assetsfairvaluedisclosure": 88601000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": 28794000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 234000,
    "deferredtaxassetsliabilitiesnet": 24000000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 52034000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 12000000,
    "operatinglosscarryforwardsbeginningexpirationyear": 2031,
    "researchanddevelopmentcreditbeginningexpirationyear": 2024,
    "orphandrugcreditbeginningexpirationyear": 2030,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 8700000,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 9700000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefits": 5298000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 2101000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsallowancefordoubtfulaccounts": 1468000,
    "deferredtaxassetstaxcreditcarryforwardsresearchandother": 36041000,
    "deferredtaxassetstaxdeferredexpenseother": 1301000,
    "deferredtaxassetsgross": 98243000,
    "deferredtaxliabilitiesgoodwillandintangibleassetsintangibleassets": 1994000,
    "deferredtaxliabilitiesother": 414000,
    "deferredincometaxliabilities": 2408000,
    "deferredtaxassetsliabilitiesbeforevaluationallowancenet": 95835000,
    "deferredtaxassetsvaluationallowance": 8155000,
    "deferredtaxassetsnet": 87680000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": -7500000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.018,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -3.576,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.109,
    "effectiveincometaxratereconciliationtaxcreditsorphandrug": 0.171,
    "effectiveincometaxratereconciliationotheradjustments": 0.027,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": -0.005,
    "effectiveincometaxratereconciliationuncertaintaxpositionspercent": 0.263,
    "effectiveincometaxratereconciliationsharebasedcompensationexcesstaxbenefitpercent": -0.01,
    "effectiveincometaxratereconciliationnondeductibleexpenseother": 0.03,
    "effectiveincometaxratecontinuingoperations": -2.981,
    "unrecognizedtaxbenefits": 9741000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 8223000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1518000,
    "currentstateandlocaltaxexpensebenefit": 1161000,
    "currentforeigntaxexpensebenefit": 81000,
    "deferredfederalincometaxexpensebenefit": -85624000,
    "deferredstateandlocalincometaxexpensebenefit": -2127000,
    "deferredforeignincometaxexpensebenefit": -16000,
    "deferredtaxassetsvaluationallowancedecrease": 103795000,
    "finitelivedintangibleassetsgross": 33000000,
    "finitelivedintangibleassetsusefulfuturelifeendmonthandyear": "2035-07",
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 1478000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 1478000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1478000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 1478000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 1478000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 15647000,
    "finitelivedintangibleassetsaccumulatedamortization": 9963000,
    "inventoryfinishedgoodsnetofreserves": 1140000,
    "inventoryrawmaterialsnetofreservesnoncurrent": 659000,
    "inventoryworkinprocessnetofreservesnoncurrent": 1109000,
    "inventoryfinishedgoodsnetofreservesnoncurrent": 1056000,
    "inventorynoncurrent": 2824000,
    "areaofrealestateproperty": 33534,
    "lesseeoperatingleaserenewalterm": "P5Y",
    "operatingleasecost": 2300000,
    "shorttermleasecost": 400000,
    "operatingleasenonleasecomponentexpense": 1400000,
    "operatingleasepayments": 2500000,
    "operatingleaseliability": 14602000,
    "operatingleaseweightedaverageremainingleaseterm1": "P8Y1M6D",
    "operatingleaseweightedaveragediscountratepercent": 0.081,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 2326000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 2332000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 2355000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 2420000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 2488000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 8182000,
    "lesseeoperatingleaseliabilitypaymentsdue": 20103000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 5501000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 88535000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 68000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 2000,
    "availableforsalesecuritiesdebtsecurities": 88601000,
    "propertyplantandequipmentusefullife": "P7Y",
    "propertyplantandequipmentgross": 4398000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 6612000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsandrestrictedstockunitsrsuoutstandingnumber": 6144430,
    "commonstockcapitalsharesreservedforfutureissuance": 7100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 3026147,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsweightedaveragevolatilityrate": 0.58,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y11M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0226,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestingperiodnumberofequalmonthlyinstallments": 36,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 22800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 526175,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 7700000,
    "sharebasedcompensationoptionawardscontractualterm": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentannualawardvestingperiodemployeesandnewdirectors": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofsharesubjecttooptionawards": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardremainingpercentageofsharesubjecttooptionawards": 0.75,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 9800000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 10.19,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 4495145,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 687500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 53,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 15000,
    "stockissuedduringperiodsharesstockoptionsexercised": 546344,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 3371836,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 4354708,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 12.21,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 18.38,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 7.94,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 14.78,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 11.47,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 10.31,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 12.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P5Y6M29D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P4Y6M10D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P5Y5M15D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 22148000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 2482000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 21200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 22039000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1649285,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 937328,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 75444,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 18.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 19.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 18.93,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 14.54,
    "allocatedsharebasedcompensationexpense": 3207000,
    "percentageofresponsibilityforpatientscostofbrandedprescriptionundermedicarepartd": 0.7,
    "advertisingexpense": 3200000,
    "numberofreportablesegments": 1,
    "restrictedcashandcashequivalents": 578000,
    "concentrationriskpercentage1": 0.38,
    "valuationallowancesandreservesbalance": 6120000,
    "valuationallowancesandreserveschargedtocostandexpense": 3138000,
    "valuationallowancesandreservesdeductions": 2205000
  }
]